Visual outcomes of scleral-fixated posterior chamber intraocular lenses in children with genetic ectopia lentis: long-term follow-up

• by Kevin Vallotton, Oussama Habra, Beatrice E. Frueh

• June 8, 2026

Dehydration during exercise may contribute to CRVO

A healthy 38-year-old woman maintained 20/20 vision despite retinal hemorrhage and venous tortuosity.

• by Andrea Surnit

• October 15, 2026

• 3 min

Correction: Aflibercept 8 mg in neovascular age-related macular degeneration and diabetic macular oedema: Translating clinical trials into clinical practice

• by Sobha Sivaprasad, Michael W. Stewart, Charles C. Wykoff, David Eichenbaum, Jean-Francois Korobelnik, Paolo Lanzetta, Varun Chaudhary, Chui Ming Gemmy Cheung, Richard Gale, Marion R. Munk, Taiji Sakamoto, Andreas Stahl, Javier Zarranz-Ventura, Tien Yin Wong, Frank G. Holz, Anat Loewenstein

• October 20, 2026

FDA approves first at-home therapy for thyroid eye disease

The first at-home subcutaneous treatment for thyroid eye disease met its primary end point in 1 of 2 phase 3 trials.

• by Mouj Hijazi

• October 16, 2026

• 2 min